PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
Werte in diesem Artikel
The Procter & Gamble Company PG has relied on price increases in recent years to offset inflationary pressures on input costs, but sustaining this strategy indefinitely presents challenges. While fiscal 2025 saw balanced contributions from volume and pricing, management has acknowledged that consumer behavior is shifting as inflation, tariffs and macro uncertainty weigh on purchasing patterns. In some categories, especially in North America and Europe, category growth has slowed, and consumers are seeking value through smaller packs, promotions or lower-priced tiers. This creates a ceiling on the effectiveness of repeated price hikes, as further increases risk driving trade-down or reducing category growth.PG’s ability to maintain pricing power depends heavily on its brand superiority and innovation pipeline. Management emphasized that categories where performance has slipped below consumer expectations have seen share pressure, but regaining superiority quickly reaccelerates growth. Examples such as innovation in Pampers, SK-II and Swiffer demonstrate that when product performance and value are clearly communicated, the company can command premium pricing even in a cost-sensitive environment.PG is working on cutting costs, improving its supply chain and focusing on its most profitable products to handle ongoing inflation. The company is aiming for up to $1.5 billion in yearly savings and is removing less important products so it can invest in the best ones. But with $200 million in extra commodity costs and $1 billion in tariffs expected in 2026, PG will need more than just price hikes. It plans to combine smarter pricing with cost savings and innovations to stay ahead.PG’s Peers: How CL & CHD Tackle InflationIn an increasingly inflationary and volatile macroeconomic environment, leading consumer goods companies like Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are leveraging strategic price increases and premium innovation to help offset rising input costs.Colgate has been using price increases alongside its premium innovation strategy to help cover rising input costs, including higher raw materials, like fats and oils and the impact of tariffs. In second-quarter 2025, pricing added 80 basis points (bps) to its gross margin, but this was more than offset by a 420-bps hit from raw and packaging material inflation. The company is also relying on “funding-the-growth” productivity initiatives, which delivered a 250-bps benefit, and is planning further pricing actions in key international markets.For Church & Dwight, price increases have been an important tool to help offset higher costs from raw materials, packaging and tariffs, but the benefit is becoming more limited. In second-quarter 2025, the company saw solid volume gains, yet pricing and mix had only a small positive impact on sales, and inflationary pressures still weighed on margins. Management is balancing selective pricing with productivity improvements, cost controls and innovation to protect profitability, acknowledging that there is a limit to how much consumers will accept higher prices before switching to cheaper alternatives. This means future margin protection will rely more on efficiency gains and premium product growth rather than relying solely on price hikes.PG’s Price Performance, Valuation & EstimatesProcter & Gamble’s shares have lost around 7.5% year to date compared with the industry’s 4.3% dip.Image Source: Zacks Investment ResearchFrom a valuation standpoint, PG trades at a forward price-to-earnings ratio of 22.01X compared with the industry’s average of 19.79X.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for PG’s fiscal 2025 and 2026 EPS indicates year-over-year growth of 2.3% and 6.3%, respectively. The company’s EPS estimates for fiscal 2025 and 2026 have moved downward in the past 30 days.Image Source: Zacks Investment ResearchProcter & Gamble currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Colgate-Palmolive Company (CL): Free Stock Analysis Report Church & Dwight Co., Inc. (CHD): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Procter Gamble und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Quelle: Zacks
Nachrichten zu Procter & Gamble Co.
Analysen zu Procter & Gamble Co.
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2025 | ProcterGamble Outperform | RBC Capital Markets | |
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2025 | ProcterGamble Outperform | RBC Capital Markets | |
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
24.04.2019 | ProcterGamble Overweight | Barclays Capital | |
14.12.2017 | ProcterGamble Buy | Deutsche Bank AG | |
27.04.2017 | ProcterGamble Hold | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets | |
24.04.2019 | ProcterGamble Neutral | Credit Suisse Group | |
23.04.2019 | ProcterGamble Neutral | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Procter & Gamble Co. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen